Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Compass Group Diversified Holdings, LLC, d/b/a Compass Diversified Holdings (“Compass Diversified” or the “Company”) (NYSE: CODI).

Compass Reports Financial Statement Issues; Subsidiary CEO Resigns Amidst Internal Investigation

On May 7, 2025, Compass Diversified reported that in April 2025 its Audit Committee “. . . commenced an internal investigation into the financing, accounting, and inventory practices of Lugano Holding, Inc. (‘Lugano’), a subsidiary and operating segment of the Company, based on concerns reported to Company management as to these practices.”

Compass Diversified further reported that “[o]n May 7, 2025 . . . the Audit Committee concluded that the Company’s consolidated financial statements and other financial information for the fiscal year ended December 31, 2024 should no longer be relied upon due to the materiality of the preliminary findings of the investigation described above. Any previously issued or filed reports, press releases, earnings releases and investor presentations or other communications describing the Company’s consolidated financial statements and other related financial information covering the fiscal year ended December 31, 2024 should also no longer be relied upon.”

Additionally, Compass Diversified reported that “[i]n connection with the ongoing investigation, on May 7, 2025, Mordechai Haim ‘Moti’ Ferder, resigned from his position as Chief Executive Officer of Lugano, and from all offices and directorships previously held with Lugano and its subsidiaries and affiliates.”

On this news, the stock price of Compass Diversified closed down more than 60% on May 8, 2025.

Class Action Filed Against Compass Diversified

On May 9, 2025, a class action complaint alleging violations of federal securities laws was filed against Compass Diversified in United States District Court, Central District of California, on behalf of investors who purchased or otherwise acquired Compass Diversified securities between May 1, 2024 and May 7, 2025, both dates inclusive (the “Class Period”).

The class action lawsuit seeks to recover compensable damages caused by the Compass Diversified Defendant’s alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

To read a copy of the complaint, click Compass Group Class Action Complaint.

Compass Diversified Investors May Have Legal Claims

Investors who acquired Compass Diversified stock during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney for a free, no-obligation evaluation of potential legal claims.

Compass Diversified shareholders can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of West Pharmaceutical Services, Inc. (“West Pharmaceutical” or the “Company”) (NYSE: WST).

On May 5, 2025, a class action complaint for violations of federal securities laws was filed against West Pharmaceutical in United States District Court, Eastern District of Pennsylvania, on behalf of investors who purchased or otherwise acquired West Pharmaceutical common stock between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”).

Throughout the Class Period, according to the complaint, the West Pharmaceutical Defendants allegedly misled investors by failing to disclose that 1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West Pharmaceutical was, in fact, experiencing significant and ongoing destocking across its high-margin High-Value Products portfolio; 2) the Company’s SmartDose device was highly dilutive to the Company’s profit margins due to operational inefficiencies; and 3) these margin pressures created the risk of costly restructuring activities, including the Company’s exit from continuous glucose monitoring contracts with long-standing customers.

To review a copy of the complaint, please click West Pharmaceutical Class Action Complaint.

West Pharmaceutical Investors May Have Legal Claims

Investors who acquired West Pharmaceutical stock during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney for a free, no-obligation evaluation of potential legal claims.

West Pharmaceutical investors can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI).

On May 2, 2025, a class action complaint for violations of federal securities laws was filed against Civitas Resources in United States District Court, District of New Jersey, on behalf of investors who purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”).

According to the complaint, throughout the Class Period, the Civitas Defendants allegedly made false and/or misleading statements and/or failed to disclose that Civitas was 1) highly likely to significantly reduce its oil production in 2025 as a result of, among other things, declines following the production peak at the DJ Basin in the fourth quarter of 2024 and a low TIL count at the end of 2024; 2) increasing its oil production would require the Company to acquire additional acreage and development locations, thereby incurring significant debt and causing the Company to sell corporate assets to offset its acquisition costs; and 3) Civitas’s financial condition would require it to implement disruptive costreduction measures including a significant workforce reduction.

To review a copy of the complaint, please click Civitas Class Action Complaint.

Civitas Investors May Have Legal Claims

Investors who acquired Civitas securities during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney for a free, no-obligation evaluation of potential legal claims.

Civitas investors can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]